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A B S T R A C T
Purpose
The aim of this study was to investigate whether a diagnosis of cancer has an impact on the cancer
patients’ job loss and re-employment and to identify the factors affecting job loss and re-
employment during 6 years of follow-up of Korean employees with cancer.
Patients and Methods
All employees except for the self-employed in Korea who were diagnosed with cancer during the 2001
calendar year (n  5,396) were identified as the first baseline patients and were followed every 3
months over 6 years to estimate the time taken to job loss. Patients who lost their job within the first
year after a diagnosis of cancer (n  1,398) were identified as the second baseline patients and were
followed up over 5 years to estimate the time taken to re-employment using the National Health
Insurance claims data. Patient demographic, socioeconomic, and clinical variables were investigated as
factors that affected job loss and re-employment.
Results
Among the first baseline cancer patients, 47.0% lost their job, and among the second baseline
patients, 30.5% were re-employed over 69 to 72 months of follow-up. Female sex, younger age
and older age, company employee, lower income, blood cancer, and brain and CNS, lung, and liver
cancer were significant predictors of early job loss or delayed re-employment.
Conclusion
The diagnosis of cancer affects cancer patients’ employment status differently according to
different factors: sex, age, type of job, income, and cancer site. Efforts should be made to support
re-employment and reduce unnecessary work cessation and disparity between different demo-
graphic and socioeconomic groups of cancer survivors.
J Clin Oncol 26:1302-1309. © 2008 by American Society of Clinical Oncology
INTRODUCTION
The 5-year survival rate for all cancers is 60%. Ap-
proximately 8million people have survived after the
initial diagnosis of cancer and treatment.1 As the
numberof cancer survivors increases, it is important
to understand the economic and workplace conse-
quences of cancer. Cancer patients who leave work
lose their regular earning and may lose important
psychological and social standing as well.2,3 From a
societal point of view, it is important to maintain
full employment.4
However, in previous studies of cancer and
work, there were inconsistent results on the effect of
a cancer diagnosis on job loss and re-employment
among cancer patients.5-12 In a systematic reviewon
the return toworkof cancer patients, variouswork-,
disease-, andtreatment-related factorswerenoted to
be related to the return to work. However, other
factors, such as demographic and socioeconomic
factors, showed no consistent results in the reported
studies. The different study patients, researchmeth-
ods, nature of the social security system, and many
other social and cultural factors may have contrib-
uted to these variations. Furthermore, the efforts to
quantify employment consequences resulting from
a cancer diagnosis have been hampered by small
sample sizes, lackof longitudinal data, andan inabil-
ity to account for different cancer sites.13
Therefore, the aim of this study was to investi-
gate an entire Korean population to determine
whether a cancer diagnosis has an impact on em-
ployment status in Korea. We investigated various
factors affecting job loss after the diagnosis of cancer
and re-employment after job loss separately. This is
because these two outcomes (job loss and re-
employment)havedifferent socio-economic associ-
ations and a different meaning to each cancer
patient as well. A unique feature of our study was
thatwe estimated these twooutcomes and identified
the factors associated with them over 6 years in all
Korean cancer patients who were employed at the
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time they were diagnosed with cancer. This study covers almost all
cancer sites. It is a longitudinal design and covers employment status
of the entire Korean population. This approach could provide other-
wise unobtainable information about job loss and re-employment of
cancer patients across different sexes, age groups, socio-economic
strata, and cancer sites.
PATIENTS AND METHODS
Patients
All employees except for the self-employed 25 to 55 years of age inKorea
whowerediagnosed for thefirst time fromApril toDecember in2001withone
of 21 types of cancer, themost commoncancers inKorea defined according to
WHO’s International Classification of Disease-10, were identified from the
National Health Insurance (NHI) claims data. There were 5,396 patients
identified (patients at the first baseline). Among them, we selected 1,398
patients who lost their job within 1 year of the cancer diagnosis (second
baseline patients) to investigate the time interval to re-employment. During
the selection, patients with six cancer sites were excluded because of the small
sample size ( 50patients) at eachof these cancer sites, because this could bias
the identification of the cancer sites that have potential influence on re-
employment. The reason for selecting patients who lost their job within the
first year as the second baseline patients was that they account for more than
half (55.1%) of the 2,538 patients who lost their job during the 6 years (72
months) of follow-up.
Employment Status and Data Construction
Employment statusof studyparticipants from2001to2006wasobtained
from administrative data of the NHI that contains the employment status of
Table 1. General Characteristics of Study Patients
Characteristic
Patients at First Baseline Patients at Second Baseline†
Total Male Female Total Male Female
No. % No. % No. % No. % No. % No. %
Total 5,296 100.0 3,941 100.0 1,355 100.0 1,398 100.0 973 100.0 425 100.0
Age group, years
25-29 281 5.3 147 3.7 134 9.9 97 6.9 51 5.2 46 10.8
30-39 1,233 23.3 820 20.8 413 38.5 269 19.2 169 17.4 100 23.5
40-49 2,263 42.7 1,678 42.6 585 43.2 556 39.8 373 38.3 183 43.1
50-55 1,519 28.7 1,296 32.9 223 16.5 476 34.1 380 39.1 96 22.6
Type of job
Public servant 1,163 22.0 819 20.8 344 25.4 103 7.4 77 7.9 26 6.1
Company employee 4,133 78.0 3,122 79.2 1,011 74.6 1,295 92.6 896 92.1 399 93.9
Equivalent household income quintiles
I (highest) 1,342 25.3 1,005 25.5 337 24.9 151 10.8 113 11.6 38 8.9
II 1,300 24.6 1,070 27.2 230 17.0 229 16.4 176 18.1 53 12.5
III 1,328 25.1 1,015 25.8 313 23.1 405 29.0 302 31.0 103 24.2
IV (lowest) 1,326 25.0 851 21.6 475 35.1 613 43.9 382 39.3 231 54.4
Cancer site
Oral cavity and nasopharynx 96 1.8 96 2.4 — — 27 1.9 27 2.8 — —
Esophagus 49 0.9 49 1.2 — — — — — — — —
Stomach 1,312 24.8 1,121 28.4 191 14.1 377 27.0 289 29.7 88 20.7
Colon and rectum 585 11.1 495 12.6 90 6.6 160 11.4 118 12.1 42 9.9
Liver 815 15.4 774 19.6 41 3.0 212 15.2 189 19.4 23 5.4
Gallbladder 81 1.5 81 2.1 — — 31 2.2 31 3.2 — —
Pancreas 95 1.8 95 2.4 — — 23 1.7 23 2.4 — —
Larynx 55 1.0 55 1.4 — — — — — — — —
Lung 420 7.9 377 9.6 43 3.2 151 10.8 127 13.1 24 5.7
Breast 411 7.8 — — 411 30.3 160 11.4 — 160 37.7
Cervix uteri 182 3.4 — — 182 13.4 — — — — —
Corpus uteri 25 0.5 — — 25 1.9 — — — — —
Ovary 83 1.6 — — 83 6.1 22 1.6 — 22 5.2
Prostate 37 0.7 37 0.9 — — — — — — —
Testis 37 0.7 37 0.9 — — — — — — —
Kidney 145 2.7 145 3.7 — — 24 1.7 24 2.5 — —
Bladder 110 2.1 110 2.8 — — 21 1.5 21 2.2 — —
Brain and CNS 154 2.9 127 3.2 27 2.0 38 2.7 38 3.9 — —
Thyroid gland 350 6.6 135 3.4 215 15.9 87 6.2 21 2.2 66 15.5
Non-Hodgkin’s lymphoma 117 2.2 95 2.4 22 1.6 26 1.9 26 2.7 — —
Leukemia 137 2.6 112 2.8 25 1.9 39 2.8 39 4.0 — —
Mortality
Death 1,820 34.4 1,572 39.9 248 18.3 599 42.8 493 50.7 106 24.9
Survival during follow-up 3,476 65.6 2,369 60.1 1,107 81.7 799 57.2 480 49.3 319 75.1
Patients who were diagnosed with cancer in 2001.
†Patients who lost their job within the first year.
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the entireKoreanpopulation.NHI claimsdata andNationalDeathCertificate
data were linked using personal identifiers. After linkage, the personal identi-
fiers were deleted. In addition, this studywas secondary data analysis. Because
of these reasons, this study was not applicable to the review from Human
Research Ethics Committee.
Statistical Analyses
The status of employment or re-employment was identified at 3-month
intervals from the administrative data of the NHI during the years 2001
through2006.Theemployment statuswas recordedasadichotomousvariable
(“employed ” or “not employed”). Consideration of the potential factors that
influenced job loss and re-employment among the cancer patients included
sex, age, type of job, socioeconomic status, and cancer site based on the
previous study results. As for the type of job, the administrative data classified
all employees into two groups: public servants or company employees. For the
economic status, equivalent income taking into account household needs
associated with household size was used. In Korea, monthly contribution to
the NHI is applied according to the family income for all employees. There-
fore,weobtainedactual family incomeusing the insurance rate for theNHI for
each employee. Equivalent income was obtained by the following methods.
Yearly family income was divided by the square root of the number of family
members.This formula iswidelyusedwhencomparingdifferent income levels
by the Organization for Economic Cooperation and Development.
TheKaplan-Meier approach for life-table estimates and the log-rank test
was used to evaluate the time taken to job loss after the cancer diagnosis, time
taken to re-employment after the job loss, and for identifying the factors that
affected the time interval. For the most common cancer sites, median time to
job loss and time taken to 25% of re-employment (first quartiles were re-
employed)were presented, because inmost cancer sites, secondbaseline study
patients could not reachmedian time to re-employment.Weused amultivar-
iate Cox proportional hazardsmodel to identify factors that were significantly
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Fig 1. Kaplan-Meier curves: time until job loss of patients from first baseline (n  5,296). (A) Total patients; (B) comparison according to sex; (C) comparison according
to type of job; and (D) comparison according to equivalent household income quintiles.
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related to the time taken to job loss after the cancer diagnosis and the time
taken to re-employment after the job loss while adjusting for the influence of
other factors.We includedallof the factorsweconsidered tohavean impacton
job loss and re-employment, which also showed statistical significance in
univariate analysis. As for cancer site, stomach cancer, which was the most
prevalent cancer andwell distributed across sexes, was chosen as the reference
cancer site. For themultivariateCoxproportional hazardsmodel, three differ-
entmodels were used depending on sex, because some cancers are sex specific
and some cancerswere represented by nomore than 50 patients, enough to be
entered in the model. In the both sexes model, the cancer sites that were
included inboth themalemodel and in the femalemodel simultaneouslywere
included. Deaths that occurred before the loss of a job or before re-
employment were coded as censored cases. The level of significance was set at
P .05. The SAS statistical package (version 8.1)14 was used for the analyses.
RESULTS
General Characteristics of the Study Patients
Table 1 shows the general characteristics of the study patients at
the first baseline, whowere diagnosed with cancer for the first time in
2001, and patients at the second baseline, who lost their jobwithin the
first year. The total number of patients at the first baseline was 5,396.
Among them, 1,398 patients lost their jobs within the first year of the
cancer diagnosis.
Time Until Job Loss and Affecting Factors
Among the 5,396 patients who were employed at the baseline,
2,538patients (47.0%) lost their job over 72months of follow-up, and
1,398 patients (25.9%) lost their job within the first year. This ac-
counted for 55.1% of the total 2,538 patients who lost their job. The
mean time to job losswas 41.4months (SE 0.4; Fig 1). The log-rank
test showed a different likelihood of job loss according to sex, type of
job, and income level. As for different cancer sites, leukemia patients
had shortest median time until job loss (Fig 2).
TheCoxproportional analysis, after adjusting for age, typeof job,
income level, and cancer site, demonstrated that the risk of job loss
owing to a cancer diagnosis was more common among the younger
(younger than 30 years) and older age (older than 50 years) groups,
company employees, the lower income group in male, female, and
both sexesmodel (Table 2). For the both sexesmodel, female patients
were more likely to lose their jobs than male patients. Regarding
cancer site, lung, brain, and CNS cancer sites and leukemia for male
patients andbrain andCNScancer site for female patients, in addition
to lung, brain, and CNS cancer site and leukemia in patients of both
sexes, had a higher risk of job loss compared with patients with stom-
ach cancer. A lower risk of job loss was associated with larynx and
kidney cancer in males patients, leukemia and ovarian cancer in fe-
male patients, and thyroid gland cancer in both sexes as compared
with stomach cancer.
Time Until Re-Employment and Affecting Factors
Among 1,398 patients who lost their job within the first year
(study patients at second baseline), 426 patients (30.5%) were re-
employed during the 69 months of follow-up. The mean time to job
loss was 45.7 months (SE  0.7; Fig 3). The log-rank test showed a
different likelihood of re-employment based on sex and type of job.
Regarding different cancer sites, patients with thyroid cancer had
shortest time until 25% of patients were re-employed (Fig 4).
The Cox proportional analysis showed cancer patients of older
age (older than 50 years) were less likely to be re-employed.However,
the type of job and income level had no significant affect on re-
employment in themalemodel, femalemodel, and both sexesmodel
(Table 2). For the both sexesmodel, female patients were less likely to
be re-employed than male patients. Regarding cancer site, leukemia
patients were less likely to be re-employed than were patients with
stomach cancer in the male model. For the female model, cancer site
was not associated with re-employment. For the both sexes model,
patients with liver cancer were less likely to be re-employed, whereas
patientswith thyroid cancerweremore likely to be re-employed com-
pared with patients with stomach cancer.
DISCUSSION
We estimated the effect of the diagnosis of cancer on the employ-
ment status in the Korean population. Among all of the study
patients who were employed and diagnosed with cancer, 47.0% of
patients lost their job during the 72months of follow-up, and 25.9%
of patients lost their job within the first year of the cancer diagnosis.
This rate is lower than that reported byChoi et al,15 whichwas limited
to small sample size and three cancer sites and was conducted only in
one cancer center in Korea and is higher than the rate reported in a
study from the United States.16 The reason for these differences is
assumed to be different study populations, sample size, and research
methods, as well as the different national and social security systems.
In the study reported by Short et al16 conducted in the United States,
the study patients were limited to one state in the United States. In a
society that does not have a national health insurance system, like the
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Fig 2. Median time to job loss and 95% CIs according to different cancer sites.
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United States, the fear of loss of health insurancemaybe an important
consideration in the decision to discontinue working if cancer treat-
ment is expensive and the potential formedical expense is great.9,17,18
This may have a significant influence on the continuation of work to
maintain health coverage. However, that is not the case in Korea,
whichhas anational health insurance system.The return towork after
job losswas shown towidely vary in a prior report (30% to 93%).This
is also likely due to a high degree of heterogeneity with regard to the
patient characteristics, including age range, cancer sites, and treat-
ment modalities.13
As for factors affecting the time taken to job loss and time taken to
re-employment, the results of this study and a previous study showed
some similarities but mostly inconsistencies. This study found that
women are more likely to lose their jobs and are less likely to be
re-employed than are men. Only one prior study16 investigated and
identified sexdisparity in termsof job loss.However, inmost previous
studies conducted in Western countries, sex was not found to influ-
ence the return to work.13 These findings should be considered with
differences of culture betweenAsian countries andWestern countries
or differences between newly developed countries and highly devel-
oped countries. The presence of women in the labor force has been
increasingwith industrialization and sexdisparities arenowvanishing
even in conventional Asian countries, but nonetheless, these cultural
factorsmay influence sexdisparity. In addition,we found thatpatients
in the older age group (older than 50 years) were more likely to lose
their job earlier andwere less likely to be re-employed comparedwith
patients in themiddle age group (age 30 to 49 years). These results are
similar to those reported by Choi et al15 and Lima et al.19 However,
Table 2. Cox Proportional Hazard Analysis According to Demographic and Socioeconomic Characteristics of Patients With Cancer
Characteristic
Time Until Job Loss of Patients From First Baseline Time Until Re-Employment of Patients From Second Baseline
Male Female Both Sexes Male Female Both Sexes
HR 95% CI HR 95% CI HR 95% CI HR 95% CI HR 95% CI HR 95% CI
Sex
Male 1.00 1.00
Female 1.59 1.40 to 1.80 0.56 0.41 to 0.75
Age, years
25-29 1.00 1.00 1.00 1.00 1.00 1.00
30-39 0.58 0.45 to 0.74 0.57 0.44 to 0.72 0.68 0.56 to 0.84 0.79 0.49 to 1.27 0.76 0.48 to 1.21 0.83 0.53 to 1.31
40-49 0.65 0.52 to 0.83 0.63 0.50 to 0.80 0.73 0.60 to 0.89 0.72 0.46 to 1.13 0.76 0.49 to 1.18 0.81 0.53 to 1.25
50-55 1.18 0.93 to 1.50 1.13 0.90 to 1.42 1.23 1.01 to 1.50 0.47 0.29 to 0.75 0.51 0.32 to 0.81 0.54 0.34 to 0.56
Type of job
Public servant 1.00 1.00 1.00 1.00 1.00 1.00
Company employee 1.43 1.32 to 1.54 1.41 1.31 to 1.52 1.49 1.38 to 1.60 1.18 0.88 to 1.58 1.24 0.93 to 1.65 1.26 0.95 to 1.67
Equivalent household income
quintiles
I (highest) 1.00 1.00 1.00 1.00 1.00
II 1.33 1.15 to 1.55 1.34 1.15 to 1.56 1.32 1.14 to 1.54 0.76 0.49 to 1.20 0.80 0.51 to 1.25 0.61 0.40 to 0.95
III 2.04 1.77 to 2.36 2.06 1.78 to 2.37 1.95 1.69 to 2.25 1.09 0.74 to 1.61 1.15 0.78 to 1.69 0.91 0.63 to 1.33
IV (lowest) 2.85 2.47 to 3.29 2.89 2.50 to 3.33 2.76 2.40 to 3.18 0.97 0.66 to 1.44 1.00 0.68 to 1.47 0.73 0.50 to 1.06
Cancer site
Stomach 1.00 1.00 1.00 1.00 1.00 1.00
Oral cavity and nasopharynx 0.99 0.73 to 1.34 0.66 0.32 to 1.35
Esophagus 1.18 0.77 to 1.81
Gallbladder 1.32 0.95 to 1.84 0.91 0.42 to 1.97
Pancreas 1.23 0.89 to 1.70 0.96 0.45 to 2.08
Larynx 0.65 0.43 to 0.99
Prostate 0.59 0.35 to 1.00
Testis 0.73 0.42 to 1.27
Kidney 0.66 0.50 to 0.88 1.08 0.56 to 2.07
Bladder 0.76 0.56 to 1.03 1.02 0.53 to 1.97
Colon and rectum 1.03 0.88 to 1.20 0.98 0.73 to 1.33 1.04 0.91 to 1.20 0.94 0.66 to 1.35 0.72 0.35 to 1.47 0.96 0.70 to 1.32
Liver 1.11 0.96 to 1.29 1.18 0.77 to 1.80 1.11 0.97 to 1.27 0.68 0.45 to 1.01 1.04 0.74 to 1.46 0.66 0.45 to 0.97
Lung 1.33 1.23 to 1.58 1.03 0.89 to 1.19 1.31 1.12 to 1.53 0.74 0.49 to 1.12 0.74 0.50 to 1.08 0.79 0.55 to 1.16
Brain and CNS 1.35 1.04 to 1.77 1.33 1.13 to 1.56 1.32 1.04 to 1.66 0.54 0.26 to 1.11
Thyroid gland 0.81 0.61 to 1.07 0.59 0.35 to 1.00 0.72 0.60 to 0.87 1.49 0.86 to 2.57 0.81 0.54 to 1.20 1.50 1.03 to 2.20
Non-Hodgkin’s lymphoma 0.97 0.70 to 1.34 0.72 0.42 to 1.25 0.95 0.71 to 1.26 0.76 0.39 to 1.46
Leukemia 1.50 1.12 to 2.01 0.66 0.50 to 0.87 1.58 1.23 to 2.03 0.25 0.10 to 0.62
Breast 1.11 0.97 to 1.27 0.99 0.46 to 2.12
Cervix uteri 1.32 0.95 to 1.82
Corpus uteri 1.22 0.89 to 1.68
Ovary 0.65 0.43 to 0.98 1.07 0.50 to 2.29
NOTE. All variables are adjusted for sex, age, type of job, equivalent household income quintiles, and cancer sites.
Abbreviation: HR, hazard ratio.
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other studies found no relationship between age and employ-
ment.11,15We found that company employeesweremore likely to lose
their jobs earlier than were public servants. This result is consistent
with previous studies.11,15 Prior reports showed that manual workers
were more likely to lose their jobs than were sedentary workers15 and
that womenwho did not belong to a union or who had blue-collar or
service industry jobs were most likely to be without a job.12 It is
assumed that company employees aremore likely to be subject to the
labor market forces than are public servants like manual workers,
those who have blue-collar or service industry jobs in other studies.
However, one study did not support these findings.16 We also found
that a low-income level was a predictor of early job loss. The same
findings were observed in a previous study conducted in Korea.15
However, interestingly, the income level had no relationship with the
time taken for reemployment in this study, and these findings have
been frequently reported in previous studies.13 We found that the
higher income groups were more protected than the lower income
groups from job loss (eg, availability of sick leave) in Korea.However,
the cumulated income or assets of the higher income groupmight be
associated with a longer leave from work, whereas the lower income
groupmight need to return to work to provide income.
In this study, some cancer sites had a statistically significant
effect on job loss and re-employment among the cancer patients.
Previous studies reported some variation in job loss among differ-
ent cancer sites and have some similaritieswith our study results.We
found that cancer sites including the lung, brain, and CNS cancer as
well as leukemia had a statistically significant effect on early job loss
compared with other cancers, which is consistent with the results of
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Fig 3. Kaplan-Meier curves: time until re-employment of patients from second baseline (n 1,358). (A) Total patients; (B) comparison according to sex; (C) comparison
according to type of job; and (D) comparison according to equivalent household income quintiles.
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previous studies.8,13,16,20 Presumably these findings result from
cancer-related disease severity, impairment of physical function, and
lower survival rates.21 In particular, patients with nervous system
cancer are likely to have problems with perception, cognition, and
movement, which are critical functions in most jobs.8,13 Our results
showed that patients with leukemia weremore likely to lose their jobs
andwere less likely to be re-employed than other cancer patients. The
treatment forbloodcancersor lymphomasgenerally requires systemic
treatment that involves radiation, chemotherapy, and stem-cell trans-
plantation, whichmay be relatedwith prolonged physical debilitation
compared with the localized treatment of early-stage solid tumors.16
The intensive and long-term treatment courses of patientswith leuke-
mia can explain this finding. The relative earlier job loss of patients
with lung cancer canbe explainedby a variety of cancer-related symp-
toms, lower quality of life,22 and higher severity, reflected by worst
survival rates.21,22 Similar results were also found in a Finnish study.20
We also found that patients with liver cancer were less likely to be
re-employed than were other cancer patients; this has not been re-
ported in other studies. Liver cancer is one of the most common
cancers inKorea because of the high infection ratewith the hepatitis B
virus.23 Liver cancer develops relatively early compared with other
cancers.23 This unique epidemiologic situation may explain the de-
layed employment among this group comparedwithother cancers. In
termsof influence of the cancer site on re-employment, this study and
previous studies showed inconsistent results, except for thyroid can-
cer.16 The early re-employment of patients with thyroid cancer com-
paredwith patientswith other cancer sites is presumably due to its less
severe clinical course and high survival rate21 in Korea.
This studyhas some limitations: First,we couldnot includeother
factors, such as cancer stage, treatment modalities, marital status,
work-related factors (eg, positive attitude of coworkers), and patient
symptoms (eg, fatigue), which were found to be predictors of job loss
and re-employment.13,15 Especially, cancer stagewas reported to have
inconsistent effects onemployment status in eachcancer site.13There-
fore, different cancer stages in each cancer sitemay have confounding
effects on the study results. But the study patients have representative
cancer stagedistributionandbecause it is not sampleddata, there isno
bias owing tounrepresentative cancer stagedistribution. In the future,
more studies need to be conducted aiming to investigate employment
consequences resulting fromdifferent cancer sites and stages and their
relations. Second, we could not identify the reasons for job loss be-
causeof limiteddataavailable.Therearepossibilities thatpatientswith
cancer quit their job because of their preference. However, the age
range of study patients was 25 to 55 years, which is most prominent
working age.Althoughwe couldnot ask cancer patients the reason for
job loss (eg, underlying disease, preference, employer, or social secu-
rity factors) directly, we could identify potential influencing factors
(patients’ clinical factors, demographic, socio-economic status, type
of job) that have association with the main reason for job loss and
re-employment instead. In the future, more studies using different
methodology (eg, survey, qualitative study) aiming to investigate the
reason for job loss and re-employment in further detail need to
be conducted.
Although this study has several limitations, the results provide
important information on the work environment of patients with
cancer. Disparities according to patients’ demographic characteristics
and socioeconomic status and inconsistent results of previous stud-
ies can be explained by different social security systems and other
cultural factors. This means that the disparity of employment can be
minimized through establishing social security systems and favorable
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Fig 4. Time taken to 25% of re-employment
and 95% CIs according to different cancer sites.
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cultures for cancer patients. Previous studies reveal that most cancer
patients received little guidance from their physicians about work.24
Monitoring of the employment status of cancer patients and greater
efforts shouldbemade to reduceunnecessarywork cessation, increase
the rate of re-employment of cancer survivors, and reduce the dispar-
ity between different demographic and socioeconomic groups.
AUTHORS’ DISCLOSURES OF POTENTIAL CONFLICTS
OF INTEREST
The author(s) indicated no potential conflicts of interest.
AUTHOR CONTRIBUTIONS
Conception and design: Jae-Hyun Park, Eun-Cheol Park, Sang-Yi Lee
Financial support: Eun-Cheol Park
Administrative support: Eun-Cheol Park, Sang-Yi Lee
Provision of study materials or patients: Sang-Yi Lee
Collection and assembly of data: Jong-Hyock Park, Sung-Gyeong Kim,
Sang-Yi Lee
Data analysis and interpretation: Jae-Hyun Park
Manuscript writing: Jae-Hyun Park, Jong-Hyock Park, Sung-Gyeong Kim
Final approval of manuscript: Eun-Cheol Park
REFERENCES
1. American Cancer Society: Cancer Facts and
Figures. Atlanta, GA, American Cancer Society,
2000
2. Holahan CK, Holahan CJ, Wonacott NL: Self
appraisal, life satisfaction, and retrospective life
choices across one and three decades. Psychol
Aging 14:238-244, 1999
3. Peteet JR: Cancer and the meaning of work.
Gen Hosp Psychiatry 22:200-205, 2000
4. Barofsky I: Work and Illness: The Cancer
Patient. New York, NY, Praeger, 1989
5. Abrahamsen AF, Loge JH, Hannisdal E, et al:
Socio-medical situation for long-term survivors of
Hodgkin’s disease: A survey of 459 patients treated
at one institution. Eur J Cancer 34:1865-1870, 1998
6. Maunsell E, Brisson C, Dubois L, et al: Work
problems after breast cancer: An exploratory quali-
tative study. Psychooncology 8:467-473, 1999
7. Salander P, Bergenheim AT, Henriksson R:
How was life after treatment of a malignant brain
tumour? Soc Sci Med 51:589-598, 2000
8. van der Wouden JC, Greaves-Otte JG,
Greaves J, et al: Occupational reintegration of long-
term cancer survivors. J Occup Med 34:1084-1089,
1992
9. Bradley CJ, Bednarek HL: Employment pat-
terns of long-term cancer survivors. Psychooncol-
ogy 11:188-198, 2002
10. Chirikos TN, Russell-Jacobs A, Cantor AB:
Indirect economic effects of long-term breast can-
cer survival. Cancer Pract 10:248-255, 2002
11. Maunsell E, Drolet M, Brisson J, et al: Work
situation after breast cancer: Results from a
population-based study. J Natl Cancer Inst 96:1813-
1822, 2004
12. Drolet M, Maunsell E, Mondor M, et al: Work
absence after breast cancer diagnosis: A population-
based study. CMAJ 173:765-771, 2005
13. Spelten ER, Spranger MAJ, Verbeek J: Fac-
tors reported to influence the return to work of
cancer survivors: A literature review. Psychooncol-
ogy 11:124-131, 2002
14. Allison PD: Survival Analysis Using the SAS
System: A Practical Guide. Cary, NC, SAS Institute
Inc, 1995
15. Choi KS, Kim EJ, Lim JH, et al: Job loss and
reemployment after a cancer diagnosis in Koreans:
A prospective cohort study. Psychooncology 16:
205-213, 2007
16. Short PF, Vasey JJ, Tunceli K: Employment
pathways in a large cohort of adult cancer survivors.
Cancer 103:1292-1301, 2005
17. Madrian JR: Employment-based health insur-
ance and job mobility: Is there evidence of job lock?
J Econ 109:27-54, 1994
18. Main DS, Nowels CT, Cavender TA, et al: A
qualitative study of work and work return in cancer
survivors. Psycho-Oncology 14:992-1004, 2005
19. de Lima M, Strom SS, Keating M, et al:
Implications of potential cure in acute myelogenous
leukemia: Development of subsequent cancer and
return to work. Blood 90:4719-4724, 1997
20. Taskila-Abrandt T, Pukkala E, Martikainen R,
et al: Employment status of Finnish cancer patients
in 1997. Psychooncology 14:221-226, 2005
21. Bae JM, Won YJ, Jung KW, et al: Survival of
Korean cancer patients diagnosed in 1995. Cancer
Treat Res 34:319-325, 2002
22. Schmitt R: Quality of life issues in lung cancer:
New symptom management strategies. Chest 103:
51S–55S, 1993 (suppl)
23. Shin HR: Epidemiology of hepatitis C virus in
Korea. Intervirology 49:18-22, 2006
24. Main DS, Nowels CT, Cavender TA, et al: A
qualitative study of work and work return in cancer
survivors. Psychooncology 14:992-1004, 2005
■ ■ ■
Job Loss and Re-Employment of Cancer Patients
www.jco.org 1309
from 128.134.207.84
Information downloaded from jco.ascopubs.org and provided by at SWETS SUBSCRIPTION SERVICE on April 30, 2015
Copyright © 2008 American Society of Clinical Oncology. All rights reserved.
